Re: efficacy of sunitinib and sorafenib in metastatic papillary and chromophobe renal cell carcinoma

Eur Urol. 2008 May;53(5):1085-6. doi: 10.1016/j.eururo.2008.02.010.

Authors

Brian Shuch¹, Arie Belldegrun

Affiliation

¹ Department of Urology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.

PMID: 18485320
DOI: 10.1016/j.eururo.2008.02.010

No abstract available

Publication types

Comment